Studies provided evidence that targeting IGF1 by miR-186-3p can regulate cervical cancer progression, and miR-125 inhibited cervical cancer progression and development by inhibiting VEGF and PI3K/AKT signaling pathway, providing more insights into the treatment of cervical cancer [2, 24]. This evidence concerns the gene VEGFA and cervical carcinoma.